Could Blood Tests be the Next Diagnostic Tool for PTSD?

Some biomarkers present in blood can help identify people who are suffering from PTSD.

Highlights:

PTSD is an anxiety disorder that develops in some people who have experienced a very stressful, frightening, or distressing event
A recent study shows that biomarkers in the blood can identify someone at high risk for or suffering from PTSD
These biomarkers have been linked to anxiety and depression in the past

Diagnosis of post-traumatic stress disorder (PTSD) can be quite challenging as it overlaps with other mental disorders. What if there was a simple test to diagnose it?

Well, it may now be possible, as scientists have found that people who are currently suffering from or face a high risk of developing post-traumatic stress disorder show particular patterns in four biomarkers, which can be measured with a simple blood test.

Post Traumatic Stress Disorder (PTSD) Strongly Linked with Alzheimer's Disease
Researchers have studied the impact of traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and genetic risk factors in a large cohort.

‘Blood tests may be the best potential diagnostic tool for PTSD.’

The findings suggest these biomarkers could be used to predict a person’s likelihood of developing PTSD, diagnose the disorder, or monitor the response to treatment.

Difficulty in Diagnosing PTSD

PTSD usually occurs after experiencing or witnessing a traumatic event. It is currently diagnosed based on symptoms such as flashbacks, difficulty sleeping or concentrating, negative thoughts, memory problems and avoidance of triggering situations. Since other disorders can have some of these same symptoms, it can be challenging to diagnose PTSD and assess changes in response to treatment.

This research, which involved over 1,000 service members, represents the largest prospective study to date to assess the biological markers of PTSD over time.

“This study provides valuable insights into the natural history of PTSD and the effectiveness of interventions, which can inform the development of treatment guidelines and improve the care for individuals suffering from PTSD,” said Stacy-Ann Miller, a researcher at the Walter Reed Army Institute of Research in Silver Spring, Maryland.

New Treatment for Chronic Pain in PTSD Patients
Post-traumatic stress disorder (PTSD) patients who are suffering from chronic pain in the body and limbs can be treated with the help of non-invasive stimulation of the vagus nerve in the neck.

“Better methods of predicting or screening for PTSD could help to overcome the disorder by identifying individuals at high risk of developing PTSD and providing them with early intervention or prevention strategies. This could potentially reduce the severity of symptoms or prevent the disorder from developing altogether.”

Miller will present the new research at Discover BMB, the American Society for Biochemistry and Molecular Biology annual meeting, March 25–28 in Seattle.

How Biomarkers can Measure PTSD

Biomarkers, which are biological processes that reflect physiological changes, can provide an objective measure of physiological changes associated with diseases like PTSD.

Novel Wristwatch Device Helps in the Treatment of Post-Traumatic Stress Disorder
Bio Ware, a novel device, has shown significant improvements in in-vivo exposure therapy treatment for post-traumatic stress disorder patients.

For the study, researchers analyzed four biomarkers in blood samples from active-duty service members taken before a 10-month deployment, three days after their return, and three to six months after their return.

The biomarkers have previously been linked to stress, depression, anxiety, and mental health disorders. The biomarkers were:

Glycolytic ratio: A measure of how the body breaks down sugar to produce energy
Arginine: An amino acid that plays a role in the immune and cardiovascular systems
Serotonin: A chemical messenger that helps regulate mood, sleep, and other functions
Glutamate: A chemical messenger that plays a role in learning and memory

The researchers divided service members into groups based on measures of PTSD and mental resilience and compared the four biomarkers among the different groups. Participants were classified as having PTSD, sub-threshold PTSD or no PTSD depending on their clinical diagnosis and PTSD symptoms.

Quiz on Post Traumatic Stress Disorder
People with PTSD find it difficult to communicate. Take this quiz on Post-Traumatic Stress Disorder to understand the condition and help you deal with it better.

The researchers classified participants’ resilience based on a combination of factors including PTSD, anxiety, sleep quality, alcohol use disorders, combat exposures, traumatic brain injury, and general physical and mental health. Previous studies have shown that people considered to have low resilience based on these measures are much more likely to develop PTSD after deployment than those with high resilience.

Comparing these biomarkers in people with different PTSD statuses and levels of resilience, the results showed that those with PTSD or subthreshold PTSD had significantly higher glycolytic ratios and lower arginine than those with high resilience. People with PTSD also had significantly lower serotonin and higher glutamate levels than those with high resilience. These associations were independent of factors such as gender, age, body mass index, smoking, and caffeine consumption.

The researchers said the biomarkers could help to predict which individuals face a high risk of PTSD, improve the accuracy of PTSD diagnosis and improve overall understanding of the drivers and effects of PTSD.

“Improved methods of screening and predicting PTSD could inform better treatment approaches by providing a deeper understanding of the underlying biological mechanisms of the disorder,” said Miller. “This could lead to the development of more targeted and effective treatments for PTSD or to identify specific subtypes of PTSD that may respond differently to different treatments.”

Researchers cautioned that more research and validation would be needed to confirm the biomarkers’ utility in real-world settings.

Reference:

Researchers identify markers of PTSD in the blood - (https://www.asbmb.org/asbmb-today/science/032823/ptsd-markers-in-blood)

Source-Medindia